Study of viral markers (human immunodeficiency virus, HBsAg and anti-HCV) among pregnant women attending the antenatal clinic

---

Original Article

Author Details : Lalman , Sudhir Singh*, Rehana Najam, Umar Farooq, Shweta R Sharma, Vasundhara Sharma, Imran Ahamad

Volume : 7, Issue : 4, Year : 2021

Article Page : 242-245

https://doi.org/10.18231/j.ijmmtd.2021.050

Suggest article by email

Get Permission

---

Abstract

Introduction: It has been recognized that population-based surveys are needed to assess the prevalence of hepatitis C virus, hepatitis B virus and HIV infection. Pregnant women can be considered as outpost populations because they are relatively unselected populations and their prevalence data may be extended to general population.
Aim/Objective: Study of viral markers (Human immunodeficiency virus, HBsAg and antiHCV among pregnant woman attending the antenatal clinic. Determination of HIV, HBsAg and HCV in the pregnant females.
Result: In this age wise distribution of HCV positive cases, five cases were positive in 17-21, age group of 22-26 twelve patients were positive, age group of 27-31 eleven patients were positive, age group of 32-36 four patients were positive and three were positive in the age above 36 years. In table number two, 7 were positive for HBsAg, 35 were positive for HCV and no one was for HIV.
Conclusion: In our study, pregnant women had a higher HCV infection rate. Occurrence of HBsAg infection was low in expectant ladies. In our area, people were very careful because they don’t want to spread HIV in their area. The public has complied with HIV/AIDS regulations. They always used condoms and never shared needles. Hence the mother could not spread HIV to the child. In order tounderstand the reasons and inferences of these findings, and provide more guidance, other research is needed.

Keywords : HIV, HBsAg and anti HCV, Pregnant women

How to cite : Lalman, Singh S, Najam R, Farooq U, Sharma S R, Sharma V, Ahamad I, Study of viral markers (human immunodeficiency virus, HBsAg and anti-HCV) among pregnant women attending the antenatal clinic. IP Int J Med Microbiol Trop Dis 2021;7(4):242-245

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.